The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Michaelson Jennifer since 2021.
This trader's CIK number is 1838061.
At the time of last reporting, Michaelson Jennifer was the Chief Scientific Officer of Cullinan Therapeutics, Inc.. (stock ticker symbol CGEM).
Also see all insider trading activities at Cullinan Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | CGEM | 0 | $0 | 4,000 | $50,040 | 0 | $0 |
| 2024 | CGEM | 0 | $0 | 95,788 | $2,300,664 | 55,606 | $239,105 |
| 2023 | CGEM | 0 | $0 | 15,949 | $183,971 | 12,000 | $51,600 |
| 2022 | CGEM | 0 | $0 | 16,000 | $218,880 | 16,000 | $68,800 |
| 2021 | CGEM | 0 | $0 | 12,000 | $299,700 | 12,000 | $51,600 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-06 | CGEM | Sale | 4,000 | 12.51 | 50,040 |
| 2024-12-18 | CGEM | Sale | 4,693 | 11.41 | 53,547 |
| 2024-12-12 | CGEM | Sale | 3,489 | 12.52 | 43,682 |
| 2024-11-05 | CGEM | Sale | 8,000 | 15.64 | 125,120 |
| 2024-09-05 | CGEM | Sale | 8,000 | 18.09 | 144,720 |
| 2024-07-05 | CGEM | Sale | 8,000 | 16.33 | 130,639 |
| 2024-05-07 | CGEM | Sale | 5,606 | 30.06 | 168,516 |
| 2024-05-06 | CGEM | Sale | 58,000 | 28.18 | 1,634,440 |
| 2024-05-07 | CGEM | Option Ex | 5,606 | 4.30 | 24,105 |
| 2024-05-06 | CGEM | Option Ex | 50,000 | 4.30 | 215,000 |
| 2023-12-21 | CGEM | Sale | 1,145 | 8.50 | 9,732 |
| 2023-12-18 | CGEM | Sale | 238 | 8.22 | 1,956 |
| 2023-12-12 | CGEM | Sale | 1,068 | 7.81 | 8,341 |
| 2023-06-20 | CGEM | Sale | 238 | 12.94 | 3,079 |
| 2023-06-12 | CGEM | Sale | 176 | 13.11 | 2,307 |
| 2023-06-06 | CGEM | Sale | 11,900 | 12.31 | 146,489 |
| 2023-06-07 | CGEM | Sale | 100 | 12.40 | 1,240 |
| 2023-06-06 | CGEM | Option Ex | 11,900 | 4.30 | 51,170 |
| 2023-06-07 | CGEM | Option Ex | 100 | 4.30 | 430 |
| 2023-05-18 | CGEM | Sale | 239 | 8.76 | 2,093 |
| 2023-05-12 | CGEM | Sale | 193 | 8.78 | 1,694 |
| 2023-04-18 | CGEM | Sale | 238 | 10.71 | 2,548 |
| 2023-04-12 | CGEM | Sale | 176 | 10.22 | 1,798 |
| 2023-03-20 | CGEM | Sale | 238 | 11.32 | 2,694 |
| 2022-11-25 | CGEM | Option Ex | 4,000 | 4.30 | 17,200 |
| 2022-11-25 | CGEM | Sale | 4,000 | 13.30 | 53,200 |
| 2022-09-27 | CGEM | Sale | 4,000 | 12.40 | 49,600 |
| 2022-09-27 | CGEM | Option Ex | 4,000 | 4.30 | 17,200 |
| 2022-07-25 | CGEM | Sale | 8,000 | 14.51 | 116,080 |
| 2022-07-25 | CGEM | Option Ex | 8,000 | 4.30 | 34,400 |
| 2021-10-18 | CGEM | Option Ex | 4,000 | 4.30 | 17,200 |
| 2021-10-18 | CGEM | Sale | 4,000 | 22.37 | 89,480 |
| 2021-09-20 | CGEM | Option Ex | 4,000 | 4.30 | 17,200 |
| 2021-09-20 | CGEM | Sale | 4,000 | 24.77 | 99,080 |
| 2021-08-18 | CGEM | Option Ex | 4,000 | 4.30 | 17,200 |
| 2021-08-18 | CGEM | Sale | 4,000 | 27.79 | 111,140 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Michaelson Jennifer (Chief Scientific Officer of Cullinan Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.